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Disclosures:
I	have	no	actual	or	potenGal	conﬂict	of	interest	in	relaGon	to	this	
program/presentaGon.	
University of Massachuse6s is Uniquely Posi9oned to 
be a Game Changer in Healthcare
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make it available for clinical decision making
Patients 
Patient self 
Reported/Device & 
Clinical Data 
Research Data 
Biospecimen 
Banking 
Clinical 
Decision 
Support 
Informed 
Clinical 
Trials 
Visualization 
& Analytics   
Our Clinical and Transla9onal Research Data Ecosystem 
Vision: Build an Integrative 
Clinical & Biospecimen Data 
Ecosystem to: 
•  Enable data driven 
research 
•  Enable translation of 
research findings to 
clinical care 
•  Make a difference in 
community and 
global health 
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Data	Lake	holds	Clinical	data	from	>2.5	Million	paGents	
representaGve	of	naGonal	diversity	
•  A	rich	source	of	data	for	studying	chronic	diseases	(e.g.	cardiovascular,	diabetes)	
•  A	useful	tool	to	study	geneGc	diseases	(e.g.	CysGc	Fibrosis,	Parkinson’s)	
•  A	mechanism	to	link	biosamples,	molecular	data	&	digital	health	data	to	clinical	
data	
UMMS Data Lake
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D3Health:	IntegraGng	Biomedical	Big	Data,	AnalyGcs,	&	
Decision	Support	
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CLINICAL CARE 
EDUCATION RESEARCH 
D3Health 
What Treatment is Be6er for Me/My Pa9ent?
Why	do	some	paGents	respond	
well/poor	to	speciﬁc	drugs?	
What	are	the	PotenGal	
Adverse	Events	for	the	new	
study?	
Why	does	the	disease	
progress	faster	for	some	
paGents?	
Am	I	Eligible	for	a	new	
study?	
How	do	I	compare	to	
other	paGents?	
All	there	clinical	trials	
targeGng	the	speciﬁc	geneGc	
alteraGons	found	in	this	
paGent?	
What	are	the	
treatment	opGons?	
Why	do	some	paGents	
develop	resistance	to	
drugs?	
What	is	involved	in	
the	study?	
Data Lake & D3Health will helps us study
Diseases….. Con9nuum of care…..Con9nuous Learning Cycles…	
Is	this	condiGon	
geneGcally	
transferable?	
What	causes	this	
disease?	
Are	there	sub-classes	
within	this	disease?	
How	does	this	PaGent		
compare	to	other	
paGents?	
What	is	the	best	
course	of	treatment?	
What	is	the	biological	
underpinning	of	this	
disease?	
•  Enables	Researchers	to	get	a	list	of	paGents	who	have	
consented	to	be	contacted	about	upcoming	studies		
Expanding	via	
•  Social	media		
•  Special	populaGon	resource	center	
•  Direct	to	paGent	tools	
•  RecruiGng	via	EHR	once	EPIC	in	place	
Data Ecosystem Components: Volunteer Registry & e-Consen9ng System
Data Ecosystem Components: OpenSpecimen for BioBanking
Single	Shop	for	Biospecimens	
•  Consent,	collect	&	barcode	
•  Create	derivaGves	&	keep	lineage	
•  Search	&	ﬁnd	
•  Scan	&	distribute	
•  Link	to	clinical	data	in	Data	Lake	&	facilitate	
query	and	request	of	biospecimens	from	
central	biobanks	(blood,	tumor,	microbiome)	
Data Ecosystem Components: LabArchives for Collec9on & 
Management of Research Data
•  Electronic	Lab	Notebook	
•  Enables	easy	access	to	data	between	lab	members	and	
collaborators	
•  Supports	secure	data	trail	(necessary	for	commercializaGon)	
•  ~	300	Users	are	using	LabArchives	
Data Ecosystem Components: Synergist for Searching & Sharing 
Research Data
“Amazon”	of	Research	data	
•  Catalog	&	Share	Experimental	Metadata	
•  Search	and	Discover	Data	&	Collaborate	
•  Connect	&	Gain	Insights	
•  Publish	&	Submit	Data	to	External	Data	
Banks	
Data Ecosystem Components: OnCore Clinical Trials Management System
•  A	leading	CTMS	plaiorm	at	Academic	Medical	Centers	
•  Integrates	well	with	EPIC	to		
•  improve	paGent	safety	
•  Improve	protocol	compliance	
		
	
	
	
• 	Went	live	on	10/21/16	
• 	Onboarding	complete	by	07/01/2017	
• 	EPIC	IntegraGon	&	go-live	by		10/01/2017	
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EHR	Primary	Concerns:	
	
Comprehensive	management	
of	a	pa.ent	over	.me		
	
Provide	high-quality		
paGent	care	
	
PaGent	safety		
	
Clinical	user	eﬃciency		
and	producGvity	
	
Research	billing	compliance	
(ability	to	separate	clinical	and	
research	charges)	
	
	
	
CTMS	Primary	Concerns:	
	
Comprehensive		
management	of	a	study	
	
Catalogs	and	tracks	all	clinical	
trial	processes	
	
AdministraGve	acGviGes	e.g.,	
budgeGng,	approval	tracking,	
study	design,	randomizaGon	
	
InvesGgator	compliance	to	
administraGve	requirements	
	
Subject	protocol	compliance		
	
Direct	reporGng	to	sponsors	
	
Overlapping	Needs:		
- 	Basic	study	informa.on	
- 	Pa.ents	associated	with	studies	
- 	Research	billing	deﬁni.on	for	study	
	
Data Ecosystem Components: ONCORE Clinical Trials Management System & 
EPIC Integra9on
ONCORE & EPIC Integra9on: Empowers Research & Care
•  Benefits for Researchers 
•  Achieve better recruitment for trials 
•  Study Teams can track the subjects  
•  Streamline collection of biospecimens 
•  Benefits for Care Providers 
•  See that a patient is on a clinical trial in the banner 
•  Get detailed information on the protocol 
•  Identify clinical trials for patients 
•  Benefits for Patients  
•  Get access to latest care especially when options are limited 
PATIENT 
CARE  
PROVIDER RESEARCHER 
Health 
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Quan9fying Pa9ent Experiences: Pa9ent Reported Outcomes
•  PaGent	Reported	Measures	
•  Compendium	describing	PRM	use	across	UMass	community	to	facilitate	prioriGzaGon	of	Epic	
build	
•  Domain	Examples:	QoL,	mental	health,	physical	funcGoning,	pain,	PTSD,	Tobacco/Alcohol/
Drug	use,	etc.		
•  Sepngs:	InpaGent,	OutpaGent,	ED	
•  PopulaGons:	Adults,	Pediatrics,	Psych	
•  PRM	administraGon	
•  Currently	Collected	using:	REDCap	
•  Working	with	Epic	Team	to	prioriGze	and	build	
Honest	Broker:	Connect	Research	&	Clinical	Data	
Clinical Data Repository 
User queries for 
clinical information 
Aggregate/  
De-identified Data 
Corresponding 
Patient Set 
generated 
De-identified 
Patient Set 
OpenSpecimen	
LabArchives	
Synergist	
Identified Patient Set 
Honest Broker 
System 
Identified Data 
-  Enables	integraGve	queries	&	extracGon	
-  Avoid	duplicaGon	of	data	
-  Full	Traceability	&	Accountability		
-  Compliance	with	HIPAA	&	regulaGons	
Rules for Diving into the Data Lake: 
Data Access Policies and Processes @ UMMS
Key	Policies:	
•  Aggregate	or	De-iden.ﬁed	data:	No	IRB	
approval	required	
•  Protected	Health	informa.on	(PHI):	IRB	
approval	required	
•  BAA	&	Security	clearance	required	while	
engaging	third-party	vendors	
Who	Can	Access	Data:	
•  Research	
•  Faculty:	Instructor	or	above	
•  Any	member	of	a	research	team	
•  Quality	&	OperaGons	
•  Administrators	and	staﬀ	at	UMMHC	
or	UMMS		
www.umassmed.edu/IT/CDP	
How:	
EHR Data for Clinical Trial Feasibility & Iden9fy Cohorts  

37	structured	interviewees	in	Germany,	UK,	Switzerland,	and	France	
indicated	strong	support	for	the	proposed	Electronic	Health	Records	for	
Clinical	Research	(EHR4CR).	All	interviewees	reported	that	using	the	
plaRorm	for	assessing	feasibility	would	enhance	the	conduct	of	clinical	
trials	and	the	majority	also	felt	it	would	reduce	workloads.	
UMMS: DLR Can Help Researchers in Be6er design of Trials & Iden9fy Cohorts 
e.g.	Botulinum	Toxin	for	Pelvic	Pain	in	Women	With	Endometriosis	(NCT01553201)	
	
INCLUSION	CRITERIA:	
• 	Female	gender	
• 	Age	between	18	and	50	
• 	History	of	endometriosis		
• 	Persistent	pelvic	pain	for	at	least	3	months	
• 	Pelvic	ﬂoor	spasm	
• 	NegaGve	pregnancy	test	
• 	Willing	to	use	reliable	method	of	contracepGon	for	the	
month	arer	botulinum	toxin	injecGon	
• 	Willing	and	able	to	give	informed	consent	
• 	Willing	and	able	to	comply	with	study	requirements	
EXCLUSION	CRITERIA:	
• 	Women	with	other	causes	of	chronic	pelvic	pain	including	infecGous,	
gastrointesGnal,	psychological	disorders,	ﬁbromyalgia	and	chronic	
faGgue	syndrome	based	on	review	of	medical	history	within	1	year	of	
ﬁrst	study	visit*.	
• 	Untreated	severe	cervical	dysplasia	or	other	gynecologic	condiGon	
within	the	past	year	based	on	medical	record	review*.	
• 	Signiﬁcant	abnormaliGes	in	the	physical	or	laboratory	examinaGon	
including	renal	and	liver	funcGon	more	than	twice	the	normal	range	
• 	Hysterectomy	and	bilateral	salpingo-oophorectomy	
• 	Pregnancy	
• 	LactaGon	
• 	Allergy	to	albumen	or	botulinum	toxin	
• 	Presence	of	anGbodies	to	botulinum	toxin	or	loss	of	response	to	
previous	injecGons	for	any	indicaGon	
• 	A	known	neuromuscular	juncGon	disorder	such	as	myasthenia	gravis	
or	Eaton-Lambert	syndrome	
• 	History	of	urinary	or	fecal	inconGnence	
• 	Known	pelvic	prolapse	
• 	How	does	protocol	design	(exclusion/inclusion)	impact	recruitment?	
• 	How	can	other	sites	selected	for	a	mulGsite	study?	
Coming	Soon………CTSA	Recruitment	RFP	–	Improve	Recruitment	using	Data	Lake	
UMMS: How to do Feasibility/Recruitment? Use DLR & Aggregate Search 
Capabili9es
 
INCLUSION CRITERIA: 
•  Female gender 
•  Age between 18 and 50 
•  History of endometriosis 
 
EXCLUSION CRITERIA: 
•  Fibromyalgia  
•  Cervical dysplasia 
•  Renal and liver function 
Integrated Clinical-Genomic 
Searches 
e.g. Female, Asian, NSCLC with 
EGFR muta9ons receiving Tarceva 
 
 
- currently not on other trials 
- consented for future contact 

CURRENT		
Q2	2017	
Q2	2017	
www.umassmed.edu/IT/CDP	
ComorbidiGes	
Concomitant	MedicaGons	
Labs	
UMMS: How to do Feasibility/Recruitment? Use DLR & Explore De-iden9ﬁed 
Data
EHR Data Can Enable Compara9ve Eﬀec9veness Studies  
EHR Data Can help in Risk Predic9on Studies
EHR Data along with Biospecimens and Genomic data can aid in 
Pharmacogenomics studies
EHR Data Can Enable Drug Repurposing Studies
EHR	Data	Can	Enable	Quality	Improvement	Studies	
UMMS: Researchers can Obtain Detailed PHI/PII Data from DLR
HIPAA	Waiver/	
Authoriza.on	
Inves.gator	
Study	Plan/DCF	
Clinical	Data	
Request	Form	
IRB	Documents	
Required	to	Obtain	PHI/PII	Data	
for	Research	Purposes	
Must	be	Consistent!	
+	 +	
www.umassmed.edu/IT/
CDP	
Study	
DataMart	
SAS,	R….	
Fully	
Automated	
Process	By	
Dec	2017		
If	you	are	requesGng	idenGﬁable	data	(PHI/
PII)	from	the	DLR,	you	must	do	so	under:	
•  A	HIPAA	Waiver	and/or	HIPAA	AuthorizaGon	
•  Other	appropriate	documentaGon			
Thanks to….
•  Advisory	Commi,ee	(K.	Luzuriaga,	C.	Kiefe,	S.	Corvera,	M.Koziel,	N.	Hafer,	G.	Wolf)	
•  Clinical	Research	Task	Force	(P.	Muldoon	&	M.	Koziel	Chairs)	
•  Clinical	Trial	Management	Steering	Group	(M.	Koziel	&	J	Mathew	Chairs)	
•  EPIC	Research	Integrated	Work	Group	(T.	Houston	&	M.	Koziel	Chairs)	
•  UMMHC	IT	(T.	Tarnowski	&	T.Eglin)	
•  My	Data	Science	&	Technology	Team	
